Why OAB treatment change is so common? “Impacta” study to evaluate reasons for treatment change

Castro-Diaz D1, Miranda P2, Sanchez-Ballester F3, Arumi D4, Lizarraga I4, Ebel-Bitoun C5

Abstract Category

Detrusor Overactivity

Abstract 344
Non-Discussion Posters
Scientific Non Discussion Poster Session 31
1. Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 2. Hospital Universitario De Fuenlabrada, Madrid, Spain, 3. Consorcio Hospital General Universitario, Valencia, Spain, 4. Pfizer Spain, 5. Pfizer France
Links

Abstract